Jennifer L. Schmachtenberg

Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters

Randy Torralva, Amy J. Eshleman, Tracy L. Swanson et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter

Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson et al. · Journal of Pharmacology and Experimental Therapeutics · 2023 · 39 citations · Full text

Medicine, Pharmacology, Psychiatry +9

Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity

Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum et al. · Journal of Pharmacology and Experimental Therapeutics · 2024 · 33 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder

Ewa Galaj, Guo‐Hua Bi, Benjamin Klein et al. · Neuropsychopharmacology · 2022 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263

Edward Ofori, Edem K. Onyameh, Uma Maheshwar Gonela et al. · European Journal of Medicinal Chemistry · 2021 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11